Thymoxamine (Opilon).
D000818:Animals; D006801:Humans; D006873:Hydroquinones / Q000627:therapeutic use*; D011928:Raynaud Disease / Q000188:drug therapy; D013565:Sympatholytics / Q000009:adverse effects / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000188:drug therapy*
D006873:Hydroquinones; D013565:Sympatholytics